Abstract
Patients with secondary immunodeficiencies (SID) can suffer complicated infections. However, it is evident that not all individuals develop an impaired immune system. Here we report the results of using a polysaccharide vaccine (S. thyphim Vi) to assess immune system status in SID patients to identify patients who may be at high risk of developing complications and may benefit from immunoglobulin replacement therapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
